Home Healthcare Biotechnology Vaccines Market

Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Route of Administration (Oral, Parenteral, Nasal), By Disease Indication (Viral, Bacterial), By Age Group (Pediatric, Adult) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR436DR | Pages: 155
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Vaccines Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Monovalent
    2. Multivalent
  2. Vaccines Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Parenteral
    3. Nasal
  3. Vaccines Market, By Disease Indication 2022-2034 (USD MILLION/ Units)
    1. Viral
      1. Hepatitis Vaccine
      2. Influenza Vaccine
      3. Human Papillomavirus (HPV) Vaccine
      4. Rotavirus Vaccine (RV)
      5. Polio Vaccine
      6. Varicella Vaccine
      7. COVID-19 Vaccine
      8. Measles, Mumps and Rubella (MMR) Vaccine
      9. Other Vaccines
    2. Bacterial
      1. Pneumococcal Conjugate Vaccine (PCV)
      2. Meningococcal Vaccine
      3. Diphtheria, Tetanus, and Pertussis Vaccines
      4. Other Vaccines
  4. Vaccines Market, By Age Group 2022-2034 (USD MILLION/ Units)
    1. Pediatric
    2. Adult
  5. Regional Vaccines Market
    1. North America
      1. North America Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      2. North America Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      3. North America Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      4. North America Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
      5. U.S. Vaccines Market
        1. U.S. Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. U.S. Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. U.S. Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. U.S. Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      6. Canada Vaccines Market
        1. Canada Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Canada Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Canada Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Canada Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
    2. Europe
      1. Europe Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      2. Europe Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      3. Europe Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      4. Europe Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
      5. U.K. Vaccines Market
        1. U.K. Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. U.K. Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. U.K. Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. U.K. Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      6. Germany Vaccines Market
        1. Germany Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Germany Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Germany Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Germany Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      7. France Vaccines Market
        1. France Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. France Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. France Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. France Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      8. Spain Vaccines Market
        1. Spain Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Spain Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Spain Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Spain Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      9. Italy Vaccines Market
        1. Italy Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Italy Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Italy Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Italy Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      10. Russia Vaccines Market
        1. Russia Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Russia Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Russia Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Russia Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      11. Nordic Vaccines Market
        1. Nordic Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Nordic Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Nordic Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Nordic Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      12. Benelux Vaccines Market
        1. Benelux Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Benelux Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Benelux Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Benelux Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      13. Rest of Europe Vaccines Market
        1. Rest of Europe Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Rest of Europe Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Rest of Europe Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Rest of Europe Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
    3. APAC
      1. APAC Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      2. APAC Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      3. APAC Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      4. APAC Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
      5. China Vaccines Market
        1. China Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. China Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. China Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. China Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      6. Korea Vaccines Market
        1. Korea Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Korea Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Korea Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Korea Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      7. Japan Vaccines Market
        1. Japan Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Japan Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Japan Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Japan Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      8. India Vaccines Market
        1. India Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. India Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. India Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. India Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      9. Australia Vaccines Market
        1. Australia Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Australia Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Australia Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Australia Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      10. Singapore Vaccines Market
        1. Singapore Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Singapore Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Singapore Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Singapore Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      11. Taiwan Vaccines Market
        1. Taiwan Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Taiwan Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Taiwan Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Taiwan Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      12. South East Asia Vaccines Market
        1. South East Asia Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. South East Asia Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. South East Asia Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. South East Asia Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      13. Rest of Asia-Pacific Vaccines Market
        1. Rest of Asia-Pacific Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Rest of Asia-Pacific Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Rest of Asia-Pacific Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Rest of Asia-Pacific Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
    4. Middle East and Africa
      1. Middle East and Africa Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      2. Middle East and Africa Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      3. Middle East and Africa Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      4. Middle East and Africa Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
      5. UAE Vaccines Market
        1. UAE Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. UAE Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. UAE Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. UAE Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      6. Turkey Vaccines Market
        1. Turkey Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Turkey Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Turkey Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Turkey Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      7. Saudi Arabia Vaccines Market
        1. Saudi Arabia Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Saudi Arabia Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Saudi Arabia Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Saudi Arabia Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      8. South Africa Vaccines Market
        1. South Africa Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. South Africa Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. South Africa Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. South Africa Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      9. Egypt Vaccines Market
        1. Egypt Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Egypt Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Egypt Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Egypt Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      10. Nigeria Vaccines Market
        1. Nigeria Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Nigeria Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Nigeria Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Nigeria Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      11. Rest of MEA Vaccines Market
        1. Rest of MEA Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Rest of MEA Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Rest of MEA Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Rest of MEA Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
    5. LATAM
      1. LATAM Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      2. LATAM Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      3. LATAM Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      4. LATAM Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
      5. Brazil Vaccines Market
        1. Brazil Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Brazil Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Brazil Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Brazil Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      6. Mexico Vaccines Market
        1. Mexico Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Mexico Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Mexico Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Mexico Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      7. Argentina Vaccines Market
        1. Argentina Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Argentina Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Argentina Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Argentina Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      8. Chile Vaccines Market
        1. Chile Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Chile Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Chile Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Chile Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      9. Colombia Vaccines Market
        1. Colombia Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Colombia Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Colombia Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Colombia Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
      10. Rest of LATAM Vaccines Market
        1. Rest of LATAM Vaccines Market By Type 2022-2034 (USD MILLION/ Units)
          1. Monovalent
          2. Multivalent
        2. Rest of LATAM Vaccines Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
          3. Nasal
        3. Rest of LATAM Vaccines Market By Disease Indication 2022-2034 (USD MILLION/ Units)
          1. Viral
            1. Hepatitis Vaccine
            2. Influenza Vaccine
            3. Human Papillomavirus (HPV) Vaccine
            4. Rotavirus Vaccine (RV)
            5. Polio Vaccine
            6. Varicella Vaccine
            7. COVID-19 Vaccine
            8. Measles, Mumps and Rubella (MMR) Vaccine
            9. Other Vaccines
          2. Bacterial
            1. Pneumococcal Conjugate Vaccine (PCV)
            2. Meningococcal Vaccine
            3. Diphtheria, Tetanus, and Pertussis Vaccines
            4. Other Vaccines
        4. Rest of LATAM Vaccines Market By Age Group 2022-2034 (USD MILLION/ Units)
          1. Pediatric
          2. Adult
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.